ClinicalTrials.gg
RecruitingNCT06206226OHDC-DCUpdated Sep 29, 2026

The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot Study

An interventional study of OHDC-DC in Depression, Depressive Disorder and Depressive Symptoms, sponsored by University of Wisconsin, Madison. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment

Updated Sep 29, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 26 studies in Depression by University of Wisconsin, Madison — 6 open to participants now, 7 under way, none of them phase 3. Depression · University of Wisconsin, Madison.

Planned enrollment
25th of 26
8 · median 137
Started
2026
with 3 others
No phase
24 of 26
6 open now
Registered
17th of 26
by date

Among the 26 studies in Depression by University of Wisconsin, Madison, this one is the 25th largest by planned enrollment, is one of 4 that started in 2026, is one of 24 with no phase, and was the 17th registered.

Depression

8,595 studies on the registry are indexed under Depression; 1,732 are open to participants now.

Browse Depression studies →

Open to participants now

6 of the 26 studies in Depression by University of Wisconsin, Madison are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,094 Depression studies recruiting now, 472 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 314 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Depression by University of Wisconsin, Madison, or all of them as a file.
02

Study summary

The goal of this clinical trial is to see if a mobile phone app can deliver depression treatment to African Americans who are depressed. The main question it aims to answer is if this treatment is effective in reducing symptoms of depression.

Participants will attend six 90-minute weekly classes via an app on their phone, and will be asked to complete surveys every week. Participants can expect to be in the study for four months.

Read the detailed description

The Oh Happy Day Class-Digital Connections (OHDC-DC) is designed for African American adults experiencing clinical depression (CD). OHDC originally comprised of 13 treatment modules focused on culturally relevant strategies to increase knowledge of depression and healthy coping behaviors aimed at reducing symptoms of clinical depression and improving health outcomes.

The Oh Happy Day Class-Digital Connections (OHDC-DC) comprise of 5 core elements of the OHDC-DC:

  1. 90-minute-weekly cognitive behavioral psycho-education classes over a 6-week period.
  2. Six classes will be offered and facilitated online in the computerized OHDC-DC.
  3. Participants will be encouraged to stay engaged between classes by digitally connecting on the app with the class content. On the app they will receive reminders and messages from staff and participants to stay digitally connected and engaged.
  4. Embedded in the classes and content is psychoeducation with an emphasis on educating participants about depression, raising awareness of mental illness with the goal of normalizing it and reducing stigma, and increasing healthy coping behaviors, and.
  5. The intervention will be delivered by a licensed mental health clinician.
03

Conditions studied

  • Depression
  • Depressive Disorder
  • Depressive Symptoms

Keywords

  • African American
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • African-American
  • Age 18 and older
  • Experiencing depression (as evidenced by a score of 5 or higher on the PHQ-9)
  • Own a mobile phone

Exclusion criteria

Exclusion Criteria:

  • Individuals who are currently receiving psychotherapy
  • Individuals who are presently experiencing suicidal ideation
  • Individuals who started psychotropic medication less than three months prior to the start of the OHDC will be excluded from the study
  • Participants scoring 25 or higher on the PHQ-9 will be screened out
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (estimated)

Study arms

  • Experimental
    Oh Happy Day Class-Digital Connections (OHDC-DC)

    Behavioral: OHDC-DC

Interventions

  • BehavioralOHDC-DC

    90-minute-weekly cognitive behavioral psycho-education classes using a mobile phone app over a 6-week period

06

What researchers measure

Primary outcomes

  1. Change in Personal Health Questionnaire Depression Scale score

    Using the 8 item Personal Health Questionnaire Depression Scale (PHQ-8), participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 24. Higher scores indicate greater degree of depression.

    Time frame: Baseline to one month post-intervention (approximately 12 weeks)

  2. Change in Generalized Anxiety Disorder 7-item (GAD-7) score

    Using the GAD-7 score, participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 24. Higher scores indicate greater degree of anxiety.

    Time frame: Baseline to one month post-intervention (approximately 12 weeks)

  3. Change in Quick Inventory of Depressive Symptomatology (QIDS)

    Using the 16-item QIDS, participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 27. Higher scores indicate greater degree of depression.

    Time frame: Baseline to one month post-intervention (approximately 12 weeks)

  4. Satisfaction with intervention

    Participants will rate their satisfaction with the intervention by answering a 9-item questionnaire with a scale of 1-7 (1= none of the time, 7= all of the time). Higher scores indicate greater satisfaction with the intervention.

    Time frame: 12 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Feb 2027, 4 months later.

Of 3,479 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 4 months is below that.

Counting every sponsor, half of 3,577 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Sep 29, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 4, 2024
First posted
Jan 16, 2024
StartEst.
Oct 2026was Sep 2026
Primary completionEst.
Feb 2027
CompletionEst.
Feb 2027
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 2026→Oct 2026
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Start date Sep 2026→Oct 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06206226
Responsible party
Sponsor
First posted
Jan 16, 2024
Start date
Oct 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Shari Barlow
Contact
shari.barlow@fammed.wisc.edu
608-265-4348
Earlise Ward, PhD
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion